Atherosclerosis is a complex pathological process that results from an interplay of genetic and environmental components. Many human beings develop accelerated atherosclerosis in the absence of known risk factors, and it has been proposed that some individuals may be genetically predisposed to develop atherosclerosis as a result of mechanisms Operating at the level of the arterial wall. Proliferation of smooth muscle cells in the arterial intima is of key importance in the development and growth of atherosclerotic lesions. In the proposed studies the hypothesis to be tested is that genetic susceptibility to atherosclerosis at the artery wall level includes a differential proliferative response of smooth muscle cells manifested through a regulatory molecule heparan sulfate proteoglycan (HSPG). The studies are possible because of the availability of genetically selected atherosclerosis-susceptible White Carneau (WC) and -resistant Show Racer (SR) pigeons. Cultured aortic smooth muscle cells of the WC pigeons demonstrate a greater proliferation capacity than those of SR. Studies of cell surface HSPG have demonstrated reduced HSPG in WC compared to SR cells. The HSPG remaining on the surface of WC have low sulfated octasaccharide and possess a low content of a unique disaccharide containing iduronic acid 2-O-SO3. When WC HSPG are isolated and added to WC or SR smooth muscle cells in culture, a low antiproliferative effect is observed. SR HSPG block the proliferation of SR cells and are less effective in WC cells. The studies proposed are designed to determine the mechanisms that result in reduced HSPG on WC cells. Based on preliminary work, WC cells produce a pool of cell surface HSPG which is transported to the cell surface but rapidly lost. Possible roles of heparanases and proteinases in this loss will be explored in cell culture studies to define a mechanism that may be unique to the WC cells. Through pulse chase and kinetic modeling, the metabolism and cellular pathways involved in the fast-turning-over pool of HSPG will be examined. Studies of oligosaccharides of cell surface HSPG indicated that the reduced antiproliferative effect of HSPG resulted from the alterations in oligosaccharide sequences and secondary modifications (e.g., sulfation and position). Proposed studies will examine the activity of N-deacetylase/N sulfotransferase, the pivotal enzyme in the production of sulfated oligosaccharide blocks in HS to determine if structural variations in the saccharides of WC HS are attributed to differential enzyme activity. The ultimate goal of the proposal is to determine the role of HSPG in relation to smooth muscle cell proliferation in atherosclerosis and conditions such as restenosis following clinical angioplasty.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL045848-04
Application #
2222502
Study Section
Pathology A Study Section (PTHA)
Project Start
1991-08-16
Project End
1998-07-31
Budget Start
1994-08-01
Budget End
1995-07-31
Support Year
4
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Veterinary Sciences
Type
Schools of Medicine
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Guo, Feng; Zarella, Christopher; Wagner, William D (2006) STAT4 and the proliferation of artery smooth muscle cells in atherosclerosis. Exp Mol Pathol 81:15-22
Bortoff, Katherine D; Wagner, William D (2005) Reduced syndecan-4 expression in arterial smooth muscle cells with enhanced proliferation. Exp Mol Pathol 78:10-6
Pillarisetti, S; Paka, L; Sasaki, A et al. (1997) Endothelial cell heparanase modulation of lipoprotein lipase activity. Evidence that heparan sulfate oligosaccharide is an extracellular chaperone. J Biol Chem 272:15753-9
Parthasarathy, N; Goldberg, I J; Sivaram, P et al. (1996) Isolation of heparin-derived oligosaccharides containing 2-O-sulfated hexuronic acids, by lipoprotein lipase affinity chromatography. J Biochem Biophys Methods 32:27-32
Shirk, R A; Church, F C; Wagner, W D (1996) Arterial smooth muscle cell heparan sulfate proteoglycans accelerate thrombin inhibition by heparin cofactor II. Arterioscler Thromb Vasc Biol 16:1138-46
Edwards, I J; Xu, H; Obunike, J C et al. (1995) Differentiated macrophages synthesize a heparan sulfate proteoglycan and an oversulfated chondroitin sulfate proteoglycan that bind lipoprotein lipase. Arterioscler Thromb Vasc Biol 15:400-9
Mas-Oliva, J; Arnold, K S; Wagner, W D et al. (1994) Isolation and characterization of a platelet-derived macrophage-binding proteoglycan. J Biol Chem 269:10177-83
Edwards, I J; Xu, H; Wright, M J et al. (1994) Interleukin-1 upregulates decorin production by arterial smooth muscle cells. Arterioscler Thromb 14:1032-9
Parthasarathy, N; Goldberg, I J; Sivaram, P et al. (1994) Oligosaccharide sequences of endothelial cell surface heparan sulfate proteoglycan with affinity for lipoprotein lipase. J Biol Chem 269:22391-6
Register, T C; Wagner, W D; Robbins, R A et al. (1993) Structural properties and partial protein sequence analysis of the major dermatan sulfate proteoglycan of pigeon aorta. Atherosclerosis 98:99-111

Showing the most recent 10 out of 11 publications